Therapies negating neuroinflammation after brain trauma

Area of Science:

• Neuroscience
• Immunology
• Trauma Research

Background:

• Traumatic brain injury (TBI) triggers complex secondary injury responses, with neuroinflammation as a key factor.
• Neuroinflammation's role is intricate, presenting both beneficial and detrimental effects post-TBI, influenced by timing, magnitude, and immune cell composition.
• Despite extensive research, effective neuroprotective therapies for TBI remain elusive, with many candidates failing in clinical trials.

Purpose of the Study:

• To review clinical trials targeting inflammation for neuroprotection after TBI.
• To discuss promising anti-inflammatory therapeutic candidates for TBI, including multifunctional and single-target agents.
• To explore strategies for modulating detrimental neuroinflammation while preserving its supportive role in brain repair.

Main Methods:

• Review of recent clinical trial findings on inflammation modulation for TBI neuroprotection.
• Discussion of preclinical and clinical data on anti-inflammatory agents for TBI.
• Analysis of the dual role of neuroinflammation in TBI and its therapeutic implications.

Main Results:

• Recent clinical trials have investigated modulating neuroinflammation as a neuroprotective strategy for TBI.
• Several anti-inflammatory candidates, both multifunctional and single-target, show promise for TBI treatment.
• Understanding the nuanced role of neuroinflammation is critical for developing effective therapies.

Conclusions:

• Targeting neuroinflammation offers a promising therapeutic avenue for TBI, balancing detrimental effects with beneficial repair functions.
• Further research into specific anti-inflammatory agents and their timing is crucial for successful clinical translation.
• This review highlights the need for therapies that selectively modulate, rather than broadly suppress, the neuroinflammatory response in TBI.